课题基金 / 基金详情

PHASE IIA TRIAL OF 1% TOPICAL CIDOFOVIR FOR TREATMENT OF HIGH-GRADE PERIANAL SQU

PHASE IIA TRIAL OF 1% TOPICAL CIDOFOVIR FOR TREATMENT OF HIGH-GRADE PERIANAL SQU
阶段%20IIA%20试验%20OF%201%%20局部%20西多福韦%20FOR%20治疗%20OF%20高等级%20肛周%20SQU
批准号：
7951592
负责人：
RONALD T. MITSUYASU
金额：
$0.15万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-04-01 至 2009-11-30
来源：
https://reporter.nih.gov/project-details/7951592
关键词：
CidofovirClinical ResearchComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantInstitutionIntraepithelial NeoplasiaLaboratoriesMethodsPatient Self-ReportPhaseResearchResearch PersonnelResourcesSafetySigns and SymptomsSourceUnited States National Institutes of Healthdiaries

项目摘要

项目成果

RONALD T. MITSUYASU的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 目的：评价局部应用西多福韦治疗高度恶性肛周鳞状上皮内瘤变(HSIL)患者的安全性和耐受性。(方法：自述每日体征及症状日记、实验室评估)
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To evaluate the safety and tolerability of topical cidofovir in HIV-infected subjects with high-grade perianal squamous intraepithelial neoplasia (perianal HSIL). (method: self-report daily sign & symptom diary, laboratory assessments)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
Studies on the Prevalence, Risk Factors and Outcomes of Cancers in HIV in India
South American Prevention of HIV Research Training Program (SAPHIR)
South American Prevention of HIV Research Training Program (SAPHIR)
海外基金